Such mechanistic insight into how TTK mediates EMT could facilitate the study of TTK expression as a biomarker for tumor aggressiveness in the context of TGF-β signaling and treatment responses in breast cancer patients. The gene discussed is TGFB1; the disease is breast carcinoma.